Pathogenic difference of respiratory syncytial virus infection in cotton rats of different ages

Microb Pathog. 2019 Dec:137:103749. doi: 10.1016/j.micpath.2019.103749. Epub 2019 Sep 12.

Abstract

Human respiratory syncytial virus (RSV) is the most common viral pathogen of lower respiratory tract infection worldwide. The virus selectively infects the respiratory epithelium, and causes diseases of variable severity in infants and the elderly. However, the differences in pathogenesis in the age groups remain poorly studied. Age is a major determinant of RSV disease, and the most severe morbidity and mortality occur in the infants and the elderly, because of the immature immunity in infants and declining immunity in old age. The cotton rat is a good model of RSV infection as it is naturally susceptible to RSV. In this study, we established an infant/adult/elderly RSV infection model in 3-week, 8-week and 30-week-old cotton rats and infected them with equal dose of RSV. This model exhibited airway neutrophils infiltration. In the 3-week-old group, higher viral load was observed in the lungs and noses, may due to low IFN-α/Mx2 levels. In contrast, the 8-week-old group had adequate IFN-α/Mx2 but exhibited the most obvious pulmonary inflammation and peribronchiolitis. Interestingly, the most severe pathology and delayed viral clearance in the lungs were observed in the 30-week-old group, may related to the increase of mucus induced by TNF-α and the lower antiviral effect of IFN-α. These results clearly revealed that an age-dependent severity of RSV disease and antiviral defense in the cotton rats, which may provide an effective model for personalized vaccine research and specific treatment strategies for different RSV age groups.

Keywords: Cotton rat; Elderly; Infant; Innate immunity; RSV.

MeSH terms

  • Animals
  • Antiviral Agents
  • Bronchoalveolar Lavage Fluid
  • Disease Models, Animal
  • Female
  • Immunity, Innate
  • Interferon-alpha / metabolism
  • Lung / immunology*
  • Lung / pathology
  • Lung / virology
  • Myxovirus Resistance Proteins / metabolism
  • Respiratory Syncytial Virus Infections / immunology*
  • Respiratory Syncytial Virus Infections / virology*
  • Respiratory Syncytial Viruses / pathogenicity*
  • Sigmodontinae
  • Viral Load

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Mx2 protein, rat
  • Myxovirus Resistance Proteins